Severe acute toxicity associated with high-dose methotrexate (MTX) therapy: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Journal of Clinical Pharmacology Année : 2006

Severe acute toxicity associated with high-dose methotrexate (MTX) therapy: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation

Domaines

Pharmacologie Sciences pharmaceutiques Cancer Médecine humaine et pathologie

Marie-Anne Estève  : Connectez-vous pour contacter le contributeur

https://hal.science/hal-01772507

Soumis le : vendredi 20 avril 2018-12:35:44

Dernière modification le : vendredi 24 mars 2023-14:53:07

Consulter sur la plateforme ISTEX

Dates et versions

hal-01772507 , version 1 (20-04-2018)

Identifiants

Citer

Marie-Anne Esteve, B. Devictor-Pierre, G. Galy, N. Andre, C. Coze, et al.. Severe acute toxicity associated with high-dose methotrexate (MTX) therapy: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation. European Journal of Clinical Pharmacology, 2006, 63 (1), pp.39 - 42. ⟨10.1007/s00228-006-0212-1⟩. ⟨hal-01772507⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

CNRS UNIV-AMU PHARMA-AMU
40 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More